Product Ref: BABAY46 Category: B
Royal Mail 2nd Class / Parcel Force 48
UK to UK :Normally arrives in 2-4 business days.
UK to Ireland :Normally arrives in 4-6 business days
UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going
Please note standered delivery is none trackable , none insured , no responsabily for lose or Damage
----------------------------------------------------------------------------------------------------------------
Royal Mail First Class / Parcel Force 24
UK to UK :Normally arrives in 1-2 business days.
UK to Ireland 3-4 business days
UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going
Please note :Trackable , Royal Mail insured up to £50.
--------------------------------------------------------------------------------------------------------
Parcel Force Express AM Guaranteed before Midday.
UK to UK only . UP to 5KG Max Weight
Arrives next day before 12 noon, requires a signature.
Parcel Forcel Terms & Conditions apply
Important: Parcel Force advise that there are some postcodes where an extended delivery time exists, and may affect the date of delivery or the service is not available.
| Category | POM-V |
| Temperature | Ambient |
| MA/VM/EU No: | 00879/4119 |
| Species |
|
| VMD Link | Product Information Database (defra.gov.uk) |
| NOAH Link | https://www.noahcompendium.co.uk/?id=-446351 |
| Dosage | Dosage and administration To ensure a correct dosage, body weight (bw) should be determined as accurately as possible to avoid underdosing. Repeated injections should be made at different injection sites. Calves 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily for 3-5 days. For acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis administer 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily for 5 days. The product can be administered by slow intravenous or subcutaneous administration. Not more than 10 ml should be administered at one subcutaneous injection site. Sheep and goats 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily by subcutaneous injection for 3 days. Not more than 6 ml should be administered at one subcutaneous injection site. Pigs 2.5 mg of enrofloxacin/kg bw, corresponding to 0.5 ml/10 kg bw, once daily by intramuscular injection for 3 days. For alimentary tract infection or septicaemia caused by Escherichia coli administer 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily by intramuscular injection for 3 days. In pigs, the injection should be made in the neck at the ear base. Not more than 3 ml should be administered at one intramuscular injection site. Dogs and cats 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily by subcutaneous injection for up to 5 days. Treatment may be initiated with injectable product and maintained with enrofloxacin tablets. Duration of treatment should be based on the duration of treatment approved for the appropriate indication in the product information of the tablet product. Use during pregnancy and lactation Laboratory studies in rats and rabbits have not produced any evidence of teratogenic effects but have shown evidence of foetotoxic effects at maternotoxic doses. The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the responsible veterinarian. |
| Withdrawals | loxacin in cats because higher doses than recommended can cause retinal damage and blindness. For cats weighing less than 5 kg, the use of Baytril 25 mg/ml solution for injection is more appropriate to avoid risk of overdosage. Degenerative changes of articular cartilage were observed in calves treated orally with 30 mg enrofloxacin/kg body weight during 14 days. The use of enrofloxacin in growing lambs at the recommended dose for 15 days caused histological changes in the articular cartilage, not associated with clinical signs. Digestive tract disorders (e.g. diarrhoea) may occur in very rare cases. These signs are generally mild and transient. Local reactions at injection site: In calves, transient local tissue reactions may occur in very rare cases and may be observed up to 14 days. In pigs, after intramuscular administration of the product, inflammatory reactions may occur. They may persist up to 28 days after the injection. In dogs, a moderate and transient local reaction (such as oedema) may occur. The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports). In cases of accidental overdoses digestive tract disorders (e.g. vomiting, diarrhoea) and neurological disorders may occur. In pigs, no adverse effects were reported after the administration of 5 times the recommended dose. Cats have been shown to suffer ocular damage after receiving doses of more than 15 mg/kg once daily for 21 consecutive days. Doses of 30 mg/kg given once daily for 21 consecutive days have been shown to cause irreversible ocular damage. At 50 mg/kg given once daily for 21 consecutive days, blindness can occur. In dogs, cattle, sheep and goats, overdose has not been documented. In accidental overdose there is no antidote and treatment should be symptomatic. Do not use enrofloxacin concomitantly with antimicrobial substances acting antagonistically to quinolones (e.g. macrolides, tetracyclines or phenicols). Do not use concurrently with theophylline as the elimination of theophylline may be delayed. Care should be taken during the concomitant use of flunixin and enrofloxacin in dogs to avoid adverse drug reactions. The decrease in drug clearances as a result of co-administration of flunixin and enrofloxacin indicates that these substances interact during the elimination phase. Thus, in dogs, the co-administration of enrofloxacin and flunixin increased the AUC and the elimination half-life of flunixin and increased the elimination half-life and reduced the Cmax of enrofloxacin. In countries where feeding of fallen stock to scavenger bird populations is permitted as a conservation measure (see Commission Decision 2003/322/EC), the possible risk to hatching success should be considered before feeding carcasses of livestock recently treated with this product. User safety People with known hypersensitivity to fluoroquinolones should avoid any contact with the product. Avoid skin and eye contact. Wash any splashes from skin or eyes immediately with water. Wash hands after use. Do not eat, drink or smoke whilst handling the product. Care should be taken to avoid accidental self-injection. If accidental self-injection occurs seek medical advice immediately. Withdrawal periods •Calves Following intravenous injection: Meat and offal: 5 days. Following subcutaneous injection: Meat and offal: 12 days. Not authorised for use in cattle producing milk for human consumption. •Sheep Meat and offal: 4 days. Milk: 72 hours. •Goats Meat and offal: 6 days. Milk: 96 hours. •Pigs Meat and offal: 13 days. Environmental safety Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. |
